Mission Creek Capital Partners’s Merck MRK Stock Holding History

Mission Creek Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$416K	Buy	+3,460	New	+$399K	0.08%	155

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mission Creek Capital Partners's MRK Position: Q1 2026 in Review

Mission Creek Capital Partners opened a new position in Merck (MRK) in Q1 2026: 3,460 shares worth $416K. The stake represents 0.08% of the portfolio and ranks #155 among its holdings.

3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Mission Creek Capital Partners held 3,460 shares of Merck worth $416K as of Q1 2026.
Merck was a new Mission Creek Capital Partners position in Q1 2026.
Merck made up 0.08% of Mission Creek Capital Partners's portfolio in Q1 2026, its #155 holding.
3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mission Creek Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.